Efficacy of 3′-azido 3′deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells
- 30 November 2001
- journal article
- Published by Elsevier in Virus Research
- Vol. 78 (1-2) , 67-78
- https://doi.org/10.1016/s0168-1702(01)00285-4
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon AlfaNew England Journal of Medicine, 1995
- Treatment of Adult T-Cell Leukemia–Lymphoma with a Combination of Interferon Alfa and ZidovudineNew England Journal of Medicine, 1995
- Regulation of Lymphocyte Survival by the BCL-2 Gene FamilyAnnual Review of Immunology, 1995
- The toxicity of azidothymidine (AZT) on human and animal cells in culture at concentrations used for antiviral therapyGenetica, 1995
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- HTLV-I proviral DNA in umbilical cord blood of babies born to carrier mothersThe Lancet, 1994
- HTLV-I/II Seroprevalence in The Gambia: A Study of Mother-Child PairsAIDS Research and Human Retroviruses, 1994
- Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease.The Journal of Experimental Medicine, 1992
- Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbitsLeukemia Research, 1990
- Intrathecal synthesis of IgG antibodies to HTLV-I supports an etiological role for HTLV-I in tropical spastic paraparesisAnnals of Neurology, 1988